Cervical cancer is a prevalent gynecological malignancy worldwide, and despite established measures for prevention, detection, and treatment at different stages, limited success has been achieved in effectively reducing its incidence. While treatments such as surgery for early-stage patients, adjuvant chemoradiotherapy based on postoperative pathology assessment of high-risk factors and intermediate risk factors, combined radiochemotherapy for patients at all stages, and systemic treatment for advanced cervical cancer have demonstrated effectiveness in numerous cases. Recent advancements in surgical pathology staging, selection of surgical approaches, options available for early-stage cases, utilization of neoadjuvant chemotherapy, novel approaches to radiotherapy administration, as well as clinical trials investigating new drugs targeting recurrent and metastatic cervical cancer have contributed to more precise and individualized treatment strategies while providing a wider range of choices. Therefore, this manuscript comprehensively discusses important developments concerning the diagnosis and treatment of cervical cancer with the aim of offering an improved reference for clinical practice.